Ashvattha Therapeutics Appoints Life Healthcare Veteran George Montgomery as Executive Chairman to Lead Corporate Development and Strategic Partnerships
With FDA Alignment and a positive Phase 2 clinical trial for its Next Generation TKI, Ashvattha Therapeutics prepares for a Phase 2b/3 trial Montgomery brings decades of experience in Life Sciences Corporate Development, M&A, and Capital Formation REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier … Read more